Markets

GW Pharmaceuticals plc (GWPH) Jumps: Stock Rises 7.6% - Tale of the Tape

GW Pharmaceuticals plc ( GWPH ) was a big mover last session, as the company saw its shares rise by roughly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 55% in the past one-month time frame.

This drug manufacturer has seen one negative revision in the past 30 days and its Zacks Consensus Estimate moved lower over the time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

GW Pharmaceuticals currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the same industry include NuVasive, Inc. ( NUVA ), Covidien plc ( COV ) and PositiveID Corporation ( PSID ). While NuVasive holds a Zacks Rank #1 (Strong Buy), Covidien and PositiveID carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

COVIDIEN PLC (COV): Free Stock Analysis Report

GW PHARMA-ADR (GWPH): Free Stock Analysis Report

NUVASIVE INC (NUVA): Free Stock Analysis Report

POSITIVEID CORP (PSID): Get Free Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

NUVA

Other Topics

Investing Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More